Melqart Asset Management »

Eli Lilly & Co. shares owned by Melqart Asset Management

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Melqart Asset Management from 13F filings

Historical chart of Melqart Asset Management investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Melqart Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Melqart Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.7M 4.1k 905.38

More positions owned by Melqart Asset Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
United States Steel Corporation (X)
Cytokinetics Com New (CYTK)
Capri Holdings SHS (CPRI)
Albertsons Cos Common Stock (ACI)
Ansys (ANSS)
R1 RCM (RCM)
Hess (HES)
Cerevel Therapeutics Hldng I (CERE)
Marvell Technology (MRVL)
Amedisys (AMED)
Seadrill 2021 (SDRL)
Silicon Motion Technology Sponsored Adr (SIMO)
Atlantica Sustainable Infr P SHS (AY)
Micron Technology (MU)

View all positions for Melqart Asset Management

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
BlackRock
Pnc Financial Services
State Street Corporation
T. Rowe Price Associates
Capital World Investors
Jpmorgan Chase & Co
PRIMECAP Management Company
Geode Capital Management
Morgan Stanley
State Farm Mutual Automobile Insurance Company
International Assets Investment Management
Bank of America Corporation

View all funds holding Eli Lilly & Co.